Attached files
| file | filename |
|---|---|
| 10-Q - PRIMARY DOCUMENT - Kraig Biocraft Laboratories, Inc | KBLK10Q2017Q3.htm |
| EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Kraig Biocraft Laboratories, Inc | exhibit311.htm |
Exhibit 32.1 and 32.2
CERTIFICATION OF DISCLOSURE PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kraig Biocraft
Laboratories, Inc. (the "Company") on Form 10-Q for the period
ending June 30, 2016as filed
with the Securities and Exchange Commission on the date hereof (the
"Report") I, Kim Thompson, President, CEO and CFO of the Company,
certify, pursuant to 18 USC section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of
my knowledge and belief:
(1) The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934;
and
(2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
Dated: November 15, 2017
|
By:
/s/ Kim Thompson
|
|
Kim
Thompson
|
|
President,
Chief Executive Officer and Chief Financial Officer (Principal
Executive Officer and Principal Financial and Accounting
Officer)
|
This certification accompanies the Report pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 and shall not, except to the
extent required by the Sarbanes-Oxley Act of 2002, be deemed filed
by the Company for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended.